Infographic: Systemic mastocytosis (SM) is a rare form of mast cell disorder characterised by abnormal proliferation and activation of mast cells

Hematology

Filter

Latest journal

All journals

September 2022

EMJ Hematology 10 [Supplement 5] 2022

This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022.

Latest articles

All articles

22nd

November

2022

Infographic: Systemic mastocytosis (SM) is a rare form of mast cell disorder characterised by abnormal proliferation and activation of mast cells

15 Mins

20th

September

2022

Management of Thrombosis in High-Risk Patients: Focus on Cancer-Associated Thrombosis

19 Mins

2nd

September

2022

Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies

Congress reviews

All congress reviews

Review of the European Hematology Association 2022 Hybrid Congress

THE EUROPEAN Hematology Association (EHA) successfully brought together clinicians and researchers from all over the world to share the latest advances in the field of haematology in its 27th Annual Congress, and its first ever hybrid congress.

The Impact of Hormone Therapy on Venous Thromboembolism Risk in Women

MILLIONS of women across the world opt for hormone-based therapies for contraception, and as a replacement therapy for relieving symptoms…

Abstracts

All abstracts

Hematology

9 Mins

21st

July

2022

EHA 2022 Abstract Highlights

Hematology

5 Mins

21st

July

2022

Zamtocabtagene Autoleucel (MB-CART2019.1): An Investigational CAR-T Cell Product with Tandem Targeting of CD19 and CD20 as a Potential Treatment Option for Patients with Relapsed/ Refractory B Cell Non-Hodgkin Lymphoma

Hematology

2 Mins

27th

July

2021

COVID-19 in Patients with Acute Leukaemia: The Experience of a Haematological Centre

Latest News

All News

Hematology

2 Mins

4th November 2022

Predicting Early Death in Acute Promyelocytic Leukaemia

Hematology

2 Mins

4th November 2022

Improving Bone Marrow Aspiration Procedure Skills and Knowledge

Hematology

2 Mins

29th September 2022

Venous Thromboembolism Risk: The Role of Obesity and Combined Oral Contraceptive Pills

Hematology

2 Mins

29th September 2022

Gene Variants Linked to Hodgkin Lymphoma

Latest Podcasts

All Podcasts

Hematology

19th August 2022

Developments in Gene Therapy for Haemophilia

In this podcast, the speakers talk about the latest developments in gene therapy for haemophilia.

Hematology

5th July 2022

Is MRD an important prognostic factor for predicting relapse in AML?

This podcast explores the potential prognostic value of measurable residual disease determination in the treatment and risk assessment of patients with acute myeloid leukaemia.

Hematology

14th March 2022

Latest Advancements in Gene Therapy for the Treatment of Haemophilia

We explore the latest advancements in gene therapy for the treatment of haemophilia, including what the future of gene therapy could mean for clinicians…

Oncology

7th March 2022

Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Patient Cases

In this episode, we have two experts in the field of direct oral anticoagulants for the treatment of cancer related venous thromboembolisms.

Latest Videos & Webinars

All Videos & Webinars

Hematology

21st November 2022

Live Webinar: The Role of Patient Empowerment as a Key Component of Effective Care in Beta Thalassemia | December 7th 4 PM GMT

Hematology

11th November 2022

A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL

Hematology

5th September 2022

Hematology

Latest journal

EMJ Hematology 10 [Supplement 5] 2022

Latest articles

Infographic: Systemic mastocytosis (SM) is a rare form of mast cell disorder characterised by abnormal proliferation and activation of mast cells

Management of Thrombosis in High-Risk Patients: Focus on Cancer-Associated Thrombosis

Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies

Congress reviews

Review of the European Hematology Association 2022 Hybrid Congress

The Impact of Hormone Therapy on Venous Thromboembolism Risk in Women

Abstracts

EHA 2022 Abstract Highlights

Zamtocabtagene Autoleucel (MB-CART2019.1): An Investigational CAR-T Cell Product with Tandem Targeting of CD19 and CD20 as a Potential Treatment Option for Patients with Relapsed/ Refractory B Cell Non-Hodgkin Lymphoma

COVID-19 in Patients with Acute Leukaemia: The Experience of a Haematological Centre

Latest News

Predicting Early Death in Acute Promyelocytic Leukaemia

Improving Bone Marrow Aspiration Procedure Skills and Knowledge

Venous Thromboembolism Risk: The Role of Obesity and Combined Oral Contraceptive Pills

Gene Variants Linked to Hodgkin Lymphoma

Latest Podcasts

Developments in Gene Therapy for Haemophilia

Is MRD an important prognostic factor for predicting relapse in AML?

Latest Advancements in Gene Therapy for the Treatment of Haemophilia

Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Patient Cases

Latest Videos & Webinars

Live Webinar: The Role of Patient Empowerment as a Key Component of Effective Care in Beta Thalassemia | December 7th 4 PM GMT

A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL

Latest updates in Advanced Systemic Mastocytosis from EHA 2022

Therapeutic Area

About Us